Metraipolis › archive › dc_dbf8cb0735ce

Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges — Europe PMC PMID:41743135

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41743135
DOI: 10.3389/fmicb.2026.1745808
License (as archived): solo-consultazione
Archived: 2026-11-05T23:46:49.976Z
SHA-256 of the archived text: 22f5a1ad91052112ac60ae8541880c265a387e17ecfdfe092fd8b5b5b8265513
Stable URL of this page: https://metraipolis.com/documento/dc_dbf8cb0735ce

How to cite

Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges — Europe PMC PMID:41743135 — Europe PMC (en), https://europepmc.org/article/MED/41743135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbf8cb0735ce (Metraipolis archive dc_dbf8cb0735ce, sha256 22f5a1ad91052112ac60ae8541880c265a387e17ecfdfe092fd8b5b5b8265513)

BibTeX

@misc{dcdbf8cb0735ce,
  title = {Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges — Europe PMC PMID:41743135},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41743135},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbf8cb0735ce; sha256 22f5a1ad91052112ac60ae8541880c265a387e17ecfdfe092fd8b5b5b8265513},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41743135. Agents can read the archived copy with the MCP tool read_document.